About the Product

Description


Sildodime 4 Tablet containing Silodosin is used for the management of benign prostatic hyperplasia (BPH), a condition characterized by prostate enlargement that causes urinary difficulties in men. It helps improve urine flow and reduce urinary symptoms.

Silodosin works as a selective alpha-1 adrenergic receptor blocker that relaxes the smooth muscles of the prostate and bladder neck, allowing easier urination and reducing symptoms such as weak stream, urgency, and incomplete bladder emptying.

The tablet is widely prescribed in urology and general medicine practice for the management of BPH and lower urinary tract symptoms, leading to consistent prescription demand.

With increasing prevalence of prostate-related conditions and growing demand for effective urology therapies, this product offers strong business potential for retailers and distributors. Its targeted mechanism of action, established clinical efficacy, and steady market demand make it a reliable product for growth in the urology segment.

Some patients may experience dizziness, headache, retrograde ejaculation, nasal congestion, fatigue, orthostatic hypotension, or diarrhea. Rarely, severe allergic reactions or significant blood pressure drops may occur and require medical attention.

Sildodime 4 Tablet is indicated for benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), urinary hesitancy, weak urine stream, incomplete bladder emptying, and nocturia. It helps improve urine flow and reduces symptoms of prostate enlargement.

This medicine should be used under medical supervision. Use cautiously in patients with kidney impairment, liver disease, or low blood pressure. Patients may experience dizziness, especially when standing up quickly, so caution is advised while driving or operating machinery.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions